Blog: Pharmaceuticals

General

Adventures at the APA

On May 18, I had the pleasure and privilege of chairing a workshop at the American Psychiatric Association’s annual meeting in Toronto. The pleasure was

Read More »
General

Musings on the Yale Symposium

On April 24, I had the pleasure of attending the symposium “New Directions & New Hopes Call for New Practices in Clinical Psychiatry.” Jointly sponsored by

Read More »
General

Stimulants and Food

The FDA recently approved lisdexamfetamine (LDF) for the treatment of the newly minted DSM-5 diagnosis of Binge Eating Disorder. This caused me some consternation and

Read More »
General

Drugs and Dementia

This study of the risks of developing dementia among those who take anticholinergic drugs has serious implications for psychiatry. This week, JAMA Internal Medicine published

Read More »
General

2015 Classes & Events

CLASSES Mad in America Continuing Education Online Courses Antipsychotics: Short and Long-term Effects (3.5CME/2.5CEU) | Dr. Sandra Steingard, MD Psychiatric Medications and Long-term Outcomes for Schizophrenia (3.0 CME/2.5CEU) | Dr.

Read More »
General

The Inner Fire Story

The catalyst for Inner Fire was a thirty-eight year old man named Zach, who while struggling with mental health challenges, tragically took his own life. 

Read More »

Join The Movement

Subscribe now to join us on our mission to create better mental health care for all.